NanosVet 出售 830 万美元以打造快速溶解的宠物药物
NanosVet 有 17 位投资者支持一项 $8.6M 的融资，而其目录中仅列出一款在售产品。
By RuntimeWire Staff · Published
Primary source: SEC
为何重要
830万美元让Andrew Green有余地将一种宠物保健贴片转变为一种兽用药物递送平台。临床证据和可重复的制造将决定NanoMelt是否能获得这一称号。
Andrew Green, founder and CEO of NanosVet, has sold $8.3 million of securities to finance a pet-health platform built around fast-dissolving oral strips, according to a 向 SEC 提交的 Form D.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.